UCLA Stroke Center
The UCLA Stroke Center is on the forefront of research, education and treatment in the field of cerebral vascular diseases. Its dedicated inpatient stroke unit offers state-of-the-art management of patients with brain infarction, brain hemorrhage and other cerebral vascular diseases. UCLA researchers have developed cutting-edge device treatments including the first device therapy for acute ischemic stroke as well as device therapies for cerebral aneurysms. The center’s clinical trials currently include testing of multiple novel clot dissolving regimens and neuroprotective agents, a UCLA study of neuroperfusion (a procedure that reverses blood flow through cerebral veins). UCLA was the first center in the United States to participate in a randomized, controlled trial of carotid and vertebral artery angioplasty. The institution established the first accredited undergraduate programs for student stroke research and stroke community education and research. The UCLA Vascular Neurology Fellowship was founded in 1996 and expanded to include an ACGME-accredited Vascular Neurology Residency in 2004. Fellows receive comprehensive, state-of-the-art clinical and research training in ischemic and hemorrhagic cerebrovascular disease.
- MR RESCUE - Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy
- ARUBA - A Randomized Trial of Unruptured Brain AVMs
- CLEAR-ER - Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
- CUFFS - Safety Study of External Counterpulsation as a Treatment for Acute Ischemic Stroke
- Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial